rs150113647
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001365999.1(SZT2):c.7562T>C(p.Val2521Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00435 in 1,614,118 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V2521M) has been classified as Uncertain significance.
Frequency
Consequence
NM_001365999.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SZT2 | ENST00000634258.3 | c.7562T>C | p.Val2521Ala | missense_variant | Exon 54 of 72 | 5 | NM_001365999.1 | ENSP00000489255.1 | ||
SZT2 | ENST00000562955.2 | c.7391T>C | p.Val2464Ala | missense_variant | Exon 53 of 71 | 5 | ENSP00000457168.1 | |||
SZT2 | ENST00000648058.1 | n.4016T>C | non_coding_transcript_exon_variant | Exon 22 of 40 | ||||||
SZT2 | ENST00000649403.1 | n.2312T>C | non_coding_transcript_exon_variant | Exon 19 of 37 |
Frequencies
GnomAD3 genomes AF: 0.00331 AC: 504AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00417 AC: 1048AN: 251402Hom.: 4 AF XY: 0.00448 AC XY: 609AN XY: 135860
GnomAD4 exome AF: 0.00446 AC: 6524AN: 1461886Hom.: 21 Cov.: 54 AF XY: 0.00437 AC XY: 3179AN XY: 727244
GnomAD4 genome AF: 0.00330 AC: 503AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.00306 AC XY: 228AN XY: 74446
ClinVar
Submissions by phenotype
not provided Benign:5
- -
- -
- -
SZT2: BP4, BS2 -
- -
Developmental and epileptic encephalopathy, 18 Benign:1
- -
not specified Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
SZT2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at